NMS·Healthcare·$454M·#100 / 520 in Healthcare
ANGO AngioDynamics, Inc.
64SOLID
CATEGORY BREAKDOWN
GROWTH0
QUALITY50
STABILITY99
VALUATION98
GOVERNANCE80
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-3.8%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
53.9%
76
> 50% strong
Cash Runway
Months of cash at current burn rate
66 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
2.6%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.4x
98
< 3x strong
Rule of 40
Growth rate plus operating margin
-12
11
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
12.3%
70
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-0.7%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ANGO WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ANGO's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.